Entity
  • Forbion

    Created in 2006
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    14,676
  • Entity types

  • Location

    Gooimeer 235, 1411 DC Naarden, Netherlands

    Naarden

    Netherlands

  • Employees

    Scale: 11-50

    Estimated: 73

  • Engaged corporates

    11
    5 7
  • Added in Motherbase

    1 year ago
Description
  • Value proposition

    Impacting the future of medicine

    Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital Partners. Today, to emphasize our value-add beyond merely providing capital, we are simply known as Forbion. For more than two decades, our investment team has built an impressive track record of sourcing, building and guiding life-sciences companies resulting in many breakthrough therapies and valuable exits.

    Forbion currently manages over €2.3 bn across ten funds. As of October 2022, Forbion holds 43 active portfolio companies bringing its investments to 95 companies to date with 46 employees.

    Forbion’s investors include the European Investment Fund (EIF), notably through its European Recovery Programme (ERP), LfA, the Dutch Venture Initiative (DVI) and AMUF facilities, and the Kreditanstalt für Wiederaufbau (KFW) through the ERP – Venture Capital Fondsfinanzierung facility.

    Developing novel drugs, Medical devices, life sciences, Health care, Therapeutics, Bioscience, and Investment

Corporate interactions BETA
Corporate TypeTweets Articles
Karista
Karista
Startup accelerator & VC, Venture Capital and Private Equity Principals
Karista
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

15 May 2024


Similar entities
Loading...
Loading...
Social network dynamics